Article
Benzbromarone pharmacokinetics and pharmacodynamics in different cytochrome P450 2C9 genotypes.
Drug metabolism and pharmacokinetics - 1 Jan 2010
Uchida Shinya, Shimada Kayoko, Misaka Shingen, Imai Hiromitsu, Katoh Yasuhiro, Inui Naoki, Takeuchi Kazuhiko, Ishizaki Takashi, Yamada Shizuo, Ohashi Kyoichi, Namiki Noriyuki, Watanabe Hiroshi
Abstract excerpt
Benzbromarone is a uricosuric drug and has been shown to be metabolized predominantly by cytochrome P450(CYP)2C9 in vitro findings. This study aims to investigate the influence of the CYP2C9 genotype on plasma levels of benzbromarone and 6-hydroxybenzbromarone, as well as uric acid lowering effects. A single oral dose pharmacokinetic and pharmacodynamic trial of benzbromarone (100 mg) was performed in 20 healthy...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
